Delivery Order SPE2DB24D2018-SPE2DB24FWSV7
Award Date
5/28/24
Potential Completion Date
5/29/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order worth $14,751.21 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The $17,725.36 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation that provides pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office Division. This is a firm fixed-price delivery order contract with a ceiling value of $47,003.95 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $26,692.61 and runs through May 31, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,369.92 and an ultimate completion date of December 5, 2024. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGES to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $20,147.10, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the larger Amerisourcebergen Corporation. This contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA). The $22,524.94 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC,...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,779.46 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $6,739.10, is for the delivery of STELARA 90 MG/ML syringes. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31,...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract. The total ceiling value of the award is $14,810.52, with an ultimate completion date of July 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is a delivery order, which suggests it is part of a larger Indefinite Delivery...